TNF and Huntington disease: Further, a plethora of soluble inflammatory mediators including C-reactive protein, Tumor necrosis factor α (TNFα), YKL-40 and atherogenic chemokines, i.e. MCP-1, CCL-5, IP-10 have been associated with adverse events or mortality in HD patients8–14.